Your browser doesn't support javascript.
loading
Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer.
Bachir, Bassel G; Souhami, Luis; Mansure, Jose João; Cury, Fabio; Vanhuyse, Marie; Brimo, Fadi; Aprikian, Armen G; Tanguay, Simon; Sturgeon, Jeremy; Kassouf, Wassim.
Afiliação
  • Bachir BG; Department of Urology, McGill University Health Center, Montreal, QC, Canada.
  • Souhami L; Division of Oncology, Division of Radiation Oncology, McGill University Health Center, Montreal, QC, Canada.
  • Mansure JJ; Department of Urology, McGill University Health Center, Montreal, QC, Canada.
  • Cury F; Division of Oncology, Division of Radiation Oncology, McGill University Health Center, Montreal, QC, Canada.
  • Vanhuyse M; Department of Medical Oncology, McGill University Health Center, Montreal, QC, Canada.
  • Brimo F; Department of Pathology, McGill University Health Center, Montreal, QC, Canada.
  • Aprikian AG; Department of Urology, McGill University Health Center, Montreal, QC, Canada.
  • Tanguay S; Department of Urology, McGill University Health Center, Montreal, QC, Canada.
  • Sturgeon J; Department of Medical Oncology, McGill University Health Center, Montreal, QC, Canada.
  • Kassouf W; Department of Urology, McGill University Health Center, Montreal, QC, Canada.
Bladder Cancer ; 3(2): 105-112, 2017 Apr 27.
Article em En | MEDLINE | ID: mdl-28516155

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article